7.9 month improvement in metastatic bowel cancer patients following microsphere radiotherapy and chemotherapy – June 2, 2015

As published on Bowel Cancer Australia’s website today, results from an Australian-led global study have shown that treatment with radiation microspheres and chemotherapy (chemo-radiotherapy) improved progression-free survival in the liver by around eight months among metastatic bowel cancer patients. The SIRFLOX study – the world’s largest study of its kind involving 530 metastatic bowel cancer patients…

Read More

Protect against pneumococcal pneumonia – May 24, 2015

“Pneumococcal pneumonia is a severe lung infection caused by the bacterium Streptococcus pneumoniae, responsible for a large proportion of pneumonia cases among those aged 65 years and above” – A/Prof Lucy Morgan.  According to Lung Foundation Australia’s ‘Lungs4Life’ research released this week, fewer than one-in-seven Australians (14 per cent) aged 18 to 74 who have…

Read More

Big pharma set for Senate tax avoidance inquiry investigation – May 22, 2015

Following an exposé of alleged “rampant off-shoring” of profits by tech-companies including Apple, Microsoft and Google, Australia’s Economics References Committee met last week to discuss widening the focus of its Senate Tax Avoidance Inquiry to include “big pharma”. The Senate Tax Avoidance Inquiry was referred to the Economics References Committee by Senate on October 2,…

Read More